REG - B.P. Marsh &Partners - New Investment

B.P. Marsh & PartnersAnnouncement

Mon 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250922:nRSV3004Aa&default-theme=true

RNS Number : 3004A  B.P. Marsh & Partners PLC  22 September 2025

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity
investor in early-stage financial services businesses, is pleased to announce
that it has acquired a 35% Cumulative Preferred Ordinary shareholding in
Salus, a start-up UK-based insurance intermediary group, specialising in
Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of
equity and a loan facility. The loan facility was partially drawn down upon
completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte")
and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting
UK-domiciled businesses including Architects, Engineers, Construction,
Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity
insurance for small to medium-sized businesses, with an initial focus on
Construction, Surveyors and Accountancy. Salus has been founded by four
experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow
and Stuart Barker whose collective experience in insurance broking and
underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a
premier, client-focused brokerage and underwriting agency, headquartered in
Bristol, providing its clients with access to the speciality Broking and
Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the
Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly
skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their
business plan of building a successful Professional Indemnity brokerage and
underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio
of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of
Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term
ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team
brings a significant amount of insurance experience, expertise, and
relationships. We look forward to working with B.P. Marsh over the years to
come to achieve our goals."

 

 For further information on B.P. Marsh, its strategy and current portfolio,
 please visit www.bpmarsh.co.uk (http://www.bpmarsh.co.uk/)  or contact:

 B.P. Marsh & Partners Plc                            +44 (0)20 7233 3112

 Brian Marsh OBE / Alice Foulk

 Nominated Adviser & Joint Corporate Broker:          +44 (0)20 7886 2500

 Panmure Liberum Limited

 David Watkins / Atholl Tweedie / Amrit Mahbubani

 Joint Corporate Broker:                              +44 (0)20 7496 3000

 Singer Capital Markets Advisory LLP

 Charles Leigh Pemberton / James Moat / Asha Chotai

 Financial PR & Investor Relations:                   bpmarsh@tavistock.co.uk (mailto:bpmarsh@tavistock.co.uk)

 Tavistock                                            +44 (0)20 7920 3150

 Simon Hudson / Katie Hopkins / Kuba Stawiski

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFFSALIFFIE



            Copyright 2019 Regulatory News Service, all rights reserved